Fairvoy Private Wealth, LLC Astrazeneca PLC Transaction History
Fairvoy Private Wealth, LLC
- $439 Billion
- Q3 2025
A detailed history of Fairvoy Private Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fairvoy Private Wealth, LLC holds 4,316 shares of AZN stock, worth $385,850. This represents 0.08% of its overall portfolio holdings.
Number of Shares
4,316
Previous 4,529
4.7%
Holding current value
$385,850
Previous $316 Million
4.62%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,498Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...